Expression of tumour-related Rac1b antagonizes B-Raf-induced senescence in colorectal cells

Henriques, Andreia FA; Barros, Patrícia; Moyer, Mary; Matos, Paulo; Jordan, Peter

http://hdl.handle.net/10400.18/3424

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
Rac1b antagonizes OIS_Cancer Letters 2015.pdf		1.43 MB	Adobe PDF	Download
1-s2.0-S0304383522004232-main.pdf		620.81 KB	Adobe PDF	Download

Send Feedback

Authors

Henriques, Andreia FA

Abstract(s)

Mutations in the BRAF oncogene have been identified as a tumor-initiating genetic event in mainly melanoma, thyroid and colon cancer, resulting in an initial proliferative stimulus that is followed by a growth arrest period known as oncogene-induced senescence (OIS). It remains unknown what triggers subsequent escape from OIS to allow further tumor progression. A previous analysis revealed that around 80% of colorectal tumors carrying a mutation in BRAF also overexpress splice variant Rac1b. We used normal NCM460 colonocytes as a model to express oncogenic B-Raf-V600E in the presence or absence of co-transfected Rac1b and then analyzed the effect on expression of senescence markers. When oncogenic B-Raf-V600E was expressed we observed the induction of the senescence-associated β-galactosidase and of the cell-cycle inhibitors p14, p15 and p21 whereas proliferation marker Ki67 was suppressed. Upon co-expression of splice variant Rac1b, but not of Rac1, the B-Raf-induced senescence phenotype was reverted and expression of the cell-cycle inhibitors downregulated in a reactive oxygen-species dependent manner. We thus provide evidence that co-expression of splice variant Rac1b counteracts B-Raf-induced senescence, indicating the selection for increased Rac1b expression as one potential mechanism by which colorectal tumor cells can escape from B-Raf-induced OIS.